相关实验视频
Updated: Jul 16, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.5K
白质病源于血管和脱髓化来源的白质病
Lin-Jie Zhang1, De-Cai Tian2, Li Yang1
1Department of Neurology, Tianjin Medical University General Hospital, Tianjin, Tianjin, China.
Stroke and vascular neurology
|September 12, 2023
概括
白质病 (WMD) 可能源于诸如多发性硬化症 (MS) 或诸如脑小血管疾病 (CSVD) 等血管问题等炎症性脱髓化疾病. 区分早期的MS和CSVD对于适当的治疗至关重要,尽管成像发现类似.
科学领域:
- 神经学 神经学
- 神经成像是一种神经成像.
- 病理学 病理学 病理学
背景情况:
- 白物质疾病 (WMD) 涉及影响神经网络的微观结构变化.
- 遗传瘤通常通过CT和MRI检测,通常呈现为多发性硬化症 (MS) 或脑小血管疾病 (CSVD).
- 由于不同的治疗策略,精确区分MS和CSVD至关重要.
研究的目的:
- 总结和对比MS和CSVD的区别特征.
- 帮助准确诊断大规模杀伤性武器的病因.
- 促进早期MS和CSVD的及时和适当的管理.
主要方法:
- 对MS和CSVD的临床和成像特征的审查.
- 对差异化特征进行比较分析.
- 用于诊断指导的文献综合.
主要成果:
- 多发性硬化和中枢神经疾病呈现重叠的临床和成像表现,特别是在早期阶段.
- 存在关键的区别,一旦确定,可以帮助差异诊断.
- 了解这些差异对于有效的毁灭性武器管理至关重要.
结论:
- 早期和准确地诊断大规模杀伤性武器的病因 (MS与CSVD) 是有效治疗的关键.
- 本综述为区分MS和CSVD提供了一个框架,基于关键特征.
- 及时诊断可以确保实施适当和独特的管理策略.
相关概念视频
Disorders of the Nervous Tissue
1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Nervous Tissue: Myelin
2.7K
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
2.7K
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517

